Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE-HEART: Apixaban vs Warfarin After Mitral or Aortic Valve Surgery
NCT07434661Phase 3Not yet recruiting
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Feb 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in Atrial fibrillation (AFib), sponsored by E. Meshalkin National Medical Research Centre. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07434661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07434661.